Evidence map›Paper›PMID 40679787›Full record

ReviewFEBS letters2025

The epithelial barrier theory proposes a comprehensive explanation for the origins of allergic and other chronic noncommunicable diseases.

Can Zeyneloglu, Huseyn Babayev, Ismail Ogulur, Sena Ardicli, Yagiz Pat, Duygu Yazici, Bingjie Zhao, Lihong Chang, Xiaoqing Liu, Paolo D'Avino and 8 more

Abstract readReview
In one paragraph

Review in FEBS letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Neuroinflammation plays a crucial role in the pathogenesis of Parkinson's disease: a systematic review and meta-analysis of clinical and biomarker evidence.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  2. Article
  3. Article
  4. Review
  5. [Gut microbiota and allergic diseases].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Can ZeynelogluSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Huseyn BabayevSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Ismail OgulurSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Sena ArdicliSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Yagiz PatSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Duygu YaziciSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Bingjie ZhaoSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Lihong ChangSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Xiaoqing LiuSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Paolo D'AvinoSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Manru LiSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Ceren BiçerSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Fatma Hacer Kurtoğlu BabayevCentre for Molecular Medicine, Institute for Vascular Signalling, Goethe University, Frankfurt am Main, Germany.
Raja DhirSeed Health Inc., Los Angeles, CA, USA.
Kari C NadeauDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Marie-Charlotte BrüggenChristine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
Mubeccel AkdisSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
Cezmi A AkdisSwiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.ORCID https://orcid.org/0000-0001-8020-019X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epithelial barrier theory proposes that modern environmental exposures compromise skin and mucosal surfaces, initiating local inflammation that propagates systemically. The theory integrates epidemiological trends, molecular mechanistic data, and emerging clinical data to show how everyday exposures cause the development and exacerbation of more than 70 chronic noncommunicable diseases. A canonical epithelial cell and barrier injury cascade takes place, generating oxidative stress with increased reactive oxygen species, the release of alarmins, and multiple chemokines and epithelial barrier disruption. The damage to epithelial barriers occurs together with microbial dysbiosis. The alerted immune system fuels various immune activation loops involving multiple cells and chemokines and links barrier leakiness to atopic, autoimmune, metabolic, and neuropsychiatric disease clusters. Supporting the one health concept, abundant exposure of domestic animals and pets to the same groups of toxic substances related to their diseases has recently become more evident. The prevalence of these preventable diseases showed an increase in parallel to industrialization and modernization and epidemiologic exposure to culprit substances throughout the whole world, with a substantial public health burden reaching trillions of dollars each year. Impact statement Modern environmental exposures compromise epithelial barriers, triggering inflammation, microbial dysbiosis, and chronic disease clusters-atopic, autoimmune, metabolic, neuropsychiatric. These preventable conditions now affect millions and impose a public health and economic burden of trillions annually in healthcare costs and lost productivity.

Indexed as

HypersensitivityNoncommunicable DiseasesAnimalsChronic DiseaseEnvironmental ExposureEpitheliumHumansalarminsepithelial barrierexposomenoncommunicable diseasesreactive oxygen speciestight junctions

Identifiers

PMID40679787
PMCPMC12643067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.